메뉴 건너뛰기




Volumn 16, Issue 9, 2002, Pages 1668-1672

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL

Author keywords

ALL; Allogeneic stem cell transplantation; MRD

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; LYMPHOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR; METHOTREXATE; MOLECULAR MARKER; OKT 3; THIOTEPA;

EID: 0036736498     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402552     Document Type: Article
Times cited : (154)

References (17)
  • 3
    • 0035885924 scopus 로고    scopus 로고
    • The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia
    • (2001) Blood , vol.98 , pp. 1982-1984
    • Uzunel, M.1    Mattsson, J.2    Jaksch, M.3    Remberger, M.4    Ringden, O.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.